Evaluating the corporate social responsibility agenda for high-cost novel therapies: roles for government and civil society. [PDF]
Wong A, Saeed G, Garner S, Kohler J.
europepmc +1 more source
The impact of ESG performance on corporate innovation-Empirical evidence from Chinese pharmaceutical listed companies. [PDF]
Li L, Wang S, Chen Y.
europepmc +1 more source
Algorithmic anxiety: AI, work, and the evolving psychological contract in digital discourse. [PDF]
Shekhar A, Saurombe MD.
europepmc +1 more source
The role of intrinsic motivation in sustaining citizen science participation among diverse participants in a corporate volunteer program. [PDF]
Allf BC, Larson LR.
europepmc +1 more source
Exploring the ethical values and social drivers behind consumer preferences for cruelty-free products. [PDF]
Enginkaya E, Sağlam MH.
europepmc +1 more source
Benevolent paternalism and player transition in Fiji soccer: insights from the Global South. [PDF]
James KE, Tuidraki HD, Tanzil SA.
europepmc +1 more source
From ethics to ecology: How ethical leadership drives environmental performance through green organizational identity and culture. [PDF]
Rihal J +3 more
europepmc +1 more source
Reconceptualizing the balanced scorecard as a communication mechanism in healthcare. [PDF]
Guo F, Huang YS, Nemoto M.
europepmc +1 more source
Positioning, power, and identity transformation among English teachers in Chinese private universities: a narrative inquiry. [PDF]
Jin Q, Kim J.
europepmc +1 more source
Same Story, Different Seller: Teaching the Public How Cannabis Models Driven by Profit Create the Same Injustices as Prohibition. [PDF]
Allen JA, Title S, Bradfield B.
europepmc +1 more source

